Yin CC - Search Results

1

The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.

Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, Arlinghaus RB, Glassman A, Sun X. Ma H, et al. Among authors: yin cc. Haematologica. 2014 Oct;99(10):1591-8. doi: 10.3324/haematol.2014.104695. Epub 2014 Jul 4. Haematologica. 2014. PMID: 24997151 Free PMC article.

2

t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.

Yin CC, Medeiros LJ, Glassman AB, Lin P. Yin CC, et al. Am J Clin Pathol. 2004 Jun;121(6):836-42. doi: 10.1309/H8JH-6L09-4B9U-3HGT. Am J Clin Pathol. 2004. PMID: 15198355

3

EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.

Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA. Yin CC, et al. Am J Clin Pathol. 2005 Feb;123(2):222-8. Am J Clin Pathol. 2005. PMID: 15842046 Review.

4

Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia.

Yin CC, Glassman AB, Lin P, Valbuena JR, Jones D, Luthra R, Medeiros LJ. Yin CC, et al. Am J Clin Pathol. 2005 Jun;123(6):840-8. doi: 10.1309/TJFF-K819-RPCL-FKJ0. Am J Clin Pathol. 2005. PMID: 15899774

5

inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.

Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D, Glassman A, Kantarjian H, Huh Y. Merzianu M, et al. Am J Clin Pathol. 2005 Nov;124(5):807-14. doi: 10.1309/3HFE-16DK-MB1D-BFMN. Am J Clin Pathol. 2005. PMID: 16203287

6

t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.

Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D. Yin CC, et al. Cancer. 2006 Apr 15;106(8):1730-8. doi: 10.1002/cncr.21797. Cancer. 2006. PMID: 16532439 Free article.

7

Molecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies.

Yin CC, Jones D. Yin CC, et al. Expert Rev Mol Diagn. 2006 Nov;6(6):831-41. doi: 10.1586/14737159.6.6.831. Expert Rev Mol Diagn. 2006. PMID: 17140370 Review.

8

Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors.

Cortes J, Jabbour E, Kantarjian H, Yin CC, Shan J, O'Brien S, Garcia-Manero G, Giles F, Breeden M, Reeves N, Wierda WG, Jones D. Cortes J, et al. Among authors: yin cc. Blood. 2007 Dec 1;110(12):4005-11. doi: 10.1182/blood-2007-03-080838. Epub 2007 Sep 4. Blood. 2007. PMID: 17785585 Free article.

9

Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors.

Jones D, Thomas D, Yin CC, O'Brien S, Cortes JE, Jabbour E, Breeden M, Giles FJ, Zhao W, Kantarjian HM. Jones D, et al. Among authors: yin cc. Cancer. 2008 Sep 1;113(5):985-94. doi: 10.1002/cncr.23666. Cancer. 2008. PMID: 18615627 Free PMC article.

10

Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays.

Yin CC, Cortes J, Galbincea J, Reddy N, Breeden M, Jabbour E, Luthra R, Jones D. Yin CC, et al. Cancer Sci. 2010 Sep;101(9):2005-10. doi: 10.1111/j.1349-7006.2010.01627.x. Cancer Sci. 2010. PMID: 20557306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters